Surveillance of cirrhotic patients using the protein induced by vitamin K absence or antagonist II (PIVKA-II)

Minerva Med. 2022 Feb;113(1):106-108. doi: 10.23736/S0026-4806.21.07952-0.

Authors

Aurora Nicolosi¹, Rinaldo Pellicano², Gian Paolo Caviglia³

Affiliations

¹ Department of Medical Sciences, University of Turin, Turin, Italy.
² Unit of Gastroenterology, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.
³ Department of Medical Sciences, University of Turin, Turin, Italy - gianpaolo.caviglia@unito.it.

PMID: 35313441
DOI: 10.23736/S0026-4806.21.07952-0

No abstract available

MeSH terms

Biomarkers
Biomarkers, Tumor
Carcinoma, Hepatocellular*
Humans
Liver Cirrhosis
Liver Neoplasms*
Protein Precursors
Prothrombin
Vitamin K
alpha-Fetoproteins / metabolism

Substances

Biomarkers
Biomarkers, Tumor
Protein Precursors
alpha-Fetoproteins
Vitamin K
acarboxyprothrombin
Prothrombin